STAT1 min. leídos
STAT Plus: Pharmalittle: Trump’s ‘Buy American’ Order Raises Doubts; Gilead Looks To Boost Global Remdesivir Output
President Trump signed an executive order Thursday directing the federal government to buy certain drugs solely from American factories.
STAT1 min. leídos
STAT Plus: Pharmalittle: U.S. Hands Glaxo And Sanofi $2.1 Billion For A Covid-19 Vaccine; Moderna Director Resigns Over Conflict Concerns
The U.S. government’s Operation Warp Speed will provide up to $2.1 billion to Sanofi and GlaxoSmithKline to fund development and manufacturing of their experimental Covid-19 vaccine.
STAT1 min. leídos
STAT Plus: Pharmalittle: Drug Makers Build Covid-19 Vaccine Supply Chains; VCs Are Still Spending On Biotechs
Drug makers racing to develop Covid-19 vaccines are already working behind the scenes to build the supply chains needed to deliver their drugs to billions of people as rapidly as…
STAT1 min. leídosScience
STAT Plus: Pharmalittle: BioNTech Expects To Seek Approval For Vaccine By Year-end; Why The FDA Chose A 50% Threshold For Covid-19 Vaccines
Peter Marks, a top FDA official, shed light on the reasoning behind the agency's choice of a 50% efficacy threshold for a Covid-19 vaccine.
STAT1 min. leídos
STAT Plus: Pharmalittle: Trump Officials Maintain Covid-19 Vaccine Won’t Be Influenced By Politics; Novartis Pays $678 Million To Settle Kickback Charges
To assuage some of that concern, the agency released a guidance that outlines conditions for approving a Covid-19 vaccine.
STAT1 min. leídosWellness
STAT Plus: Pharmalittle: FDA To Issue Guidance On Covid-19 Vaccines; What Remdesivir Pricing May Really Mean
Gilead Sciences, in a self-described effort to do “the right and responsible thing,” may have just set a precedent its industry peers will come to resent.
STAT1 min. leídosScience
STAT Plus: Pharmalittle: Sanofi To Cut Hundreds Of Jobs; Former BARDA Chief Claims Azar Is Sabotaging His New Job
Sanofi is considering cutting hundreds of jobs and will discuss potential steps with staff representatives over the coming days.
STAT1 min. leídos
STAT Plus: Pharmalittle: Europe Nears A Deal For J&J Covid-19 Vaccine; Biogen Loses A Big Patent Case
The European Commission is in advanced talks with Johnson & Johnson to reserve or buy up-front doses of its Covid-19 vaccine under development.
STAT1 min. leídosPolitics
STAT Plus: Pharmalittle: U.S. Chamber Wants Transparency Around Covid-19 Vaccines; EU To Pump Billions Into Vaccine Deals
The U.S. Chamber of Commerce has suggested that more transparency is needed surrounding the Covid-19 vaccine deals that are being struck between drug makers and governments.
STAT1 min. leídos
STAT Plus: Pharmalittle: Groups Backed By Pharma Oppose Equitable Covid-19 Pricing; AstraZeneca Strikes Big Covid-19 Vaccine Deal
AstraZeneca found partners to manufacture and distribute 2 billion doses of an experimental Covid-19 vaccine created by Oxford University.
STAT1 min. leídosWellness
STAT Plus: Pharmalittle: Administration Mishandled Initial Remdesivir Distribution; AstraZeneca Lung Cancer Drug Shows Big Benefit
The Trump administration mishandled the initial distribution of remedesivir, the experimental Gilead Sciences Covid-19 medicine, delaying treatment to some critically ill patients.
STAT1 min. leídos
STAT Plus: Pharmalittle: Moderna Executives Cashed Out Big Time; Should We Have ‘Quality Scores’ For Manufacturing Drugs?
A group of academics and pharmacists argue that assigning scores based on a mix of regulatory actions and chemical analysis would motivate drug makers to produce more “quality” drugs.
STAT1 min. leídos
STAT Plus: Phlow CEO Speaks Out On Criticism Of His Record, Plans For A Drug Ingredient Stockpile, And A Huge Government Contract
STAT spoke with Phlow CEO Eric Edwards about the criticism over his track record, Phlow's plan to create a national drug ingredient stockpile, and the huge government contract the company…
STAT1 min. leídosSociety
STAT Plus: Pharmalittle: Coronavirus Vaccine May Not Be A Cure-all; Hydroxychloroquine Fails In A Covid-19 Study
#Covid19 vaccines in development may be more like those that protect against influenza — reducing the risk of contracting the disease and of experiencing severe symptoms should infection occur.
STAT2 min. leídos
STAT Plus: Pharmalittle: White House Signs Deal For U.S.-made Generics To Fight Covid-19; Gilead Expands Remdesivir Donations
The Trump administration signed a contract with Phlow, a new company in Richmond, Va., to make generic drugs and pharmaceutical ingredients needed to treat Covid-19.
STAT1 min. leídosWellness
STAT Plus: Pharmalittle: France Piles Pressure On Sanofi Over Covid-19 Vaccine; GOP Fails To Land A Punch On Bright
Under an “America First” president, public health experts worry the U.S. could seek to gobble up early supplies of Covid-19 vaccine.
STAT1 min. leídos
STAT Plus: Pharmalittle: Sanofi Walks Back Covid-19 Vaccine Remarks; Trump To Name Vaccine Czar With Conflicts
Sanofi insisted it would make its Covid-19 vaccine available in all countries, hours after chief executive Paul Hudson said the U.S. will get first access.
STAT1 min. leídosSociety
STAT Plus: Pharmalittle: Hydroxychloroquine Fails To Help Patients In A Study; What Will States Do With The Old Malaria Drug Now?
After doubts arose about whether hydroxychloroquine is safe and effective for treating Covid-19, states are donating supplies to patients who need them to treat other illnesses or seeking refunds.
STAT1 min. leídos
STAT Plus: Pharmalittle: Gilead Faces Remdesivir Production Challenges; Will Scientists Run Out Of Covid-19 Trial Patients?
Gilead faces the challenge of scaling up production of remdesivir, its experimental #Covid19 drug that the whole world may want.
STAT1 min. leídos
STAT Plus: Pharmalittle: U.S. Plans ‘Operation Warp Speed’ For A Covid-19 Vaccine; Gilead Vows Remdesivir Will Be Accessible
The Trump administration is organizing a Manhattan Project-style effort to drastically cut the time needed to develop a #coronavirus vaccine.
STAT2 min. leídos
STAT Plus: Pharmalittle: Japan Plans Fast-track Review Of Gilead Drug For Covid-19; Most Americans Think Trump Whiffed On Drug Prices
The Japanese prime minister said Japan is on the verge of initiating a fast-track approval process for remdesivir, the experimental Gilead Sciences antiviral being tested against the #coronavirus.
STAT1 min. leídosSociety
STAT Plus: Pharmalittle: Thousands Sign Up For Trials Studying Hydroxycholoroquine; Gilead Drug Fails To Help Covid-19 Patients
Thousands of Covid-19 patients worldwide are signing up for studies exploring whether antimalaria drugs fight off infections of the novel coronavirus.
STAT1 min. leídos
STAT Plus: Pharmalittle: Early Data Suggests Gilead Covid-19 Drug Works; Did FDA Drop Standards Too Far In Hunt For Chloroquine?
The U.S. government is pledging up to $483 million to accelerate the development of a Moderna experimental Covid-19 vaccine.
STAT2 min. leídosSociety
Opinion: Faces Of Health Care Workers On The Frontlines Of The Covid-19 Fight
Health care workers who are essential to the fight against #Covid19 but who tend to go unrecognized for their efforts remind me — and I hope they remind you, too…
STAT6 min. leídos
Coronavirus Pandemic Sets Up Potential Breakout Moment For Virtual Mental Health Care
Companies offering virtual mental health care say they’re seeing a massive surge in interest amid the #Covid19 pandemic — and are scrambling to meet that demand.
STAT6 min. leídosSociety
‘We Need An Army’: Hiring Of Coronavirus Trackers Seen As Key To Curbing Disease Spread
“We need an army of 300,000 people” to find the contacts of people infected with the #coronavirus, said former CDC director Tom Frieden.
STAT3 min. leídos
Brazilian Lawmakers Propose Compulsory Licensing For Covid-19 Products
Brazil has become the latest country in which some lawmakers are seeking to issue compulsory licenses for medicines and vaccines to combat the novel coronavirus.
STAT4 min. leídosSociety
Opinion: To Restart The Economy, Employers Need To Lead The Way On Covid-19 Testing, Vaccination
Creating a consensus on testing and certification, driven by employers willing and able to take early action, will accelerate America's return to work. No employer in America can afford to…
STAT4 min. leídos
Opinion: Lost Opportunities From FDA, NIH Inaction When Sponsors Fail To Report Clinical Trial Results
Not enforcing the Food and Drug Administration Amendments Act puts Americans at greater risk of wasting money on useless medical products and being injured by unsafe ones.
STAT4 min. leídosSociety
Opinion: Professionalism Drives Health Care Workers To Treat Patients With Covid-19. We Mustn’t Jeopardize It
Americans admire health care workers, and that admiration has justifiably grown during this crisis. But we should realize that the professionalism underneath their work is fragile and needs to be…
… o descubre algo nuevo